Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 12/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24117778 | 1.00 | GPR119 (0.56) | GPR119MAOAMAOBMEN1ALDH1A1 | |
| SCHEMBL21824803 | 1.00 | GPR119 (0.56) | GPR119MAOAMAOBMEN1ALDH1A1 | |
| SCHEMBL6881795 | 0.85 | GPR119 (0.50) | GPR119ALDH1A1MAPTKMT2A | |
| SCHEMBL6881830 | 0.85 | GPR119 (0.50) | GPR119ALDH1A1MAPTKMT2A | |
| SCHEMBL6881798 | 0.85 | GPR119 (0.50) | GPR119ALDH1A1MAPTKMT2A | |
| SCHEMBL20002136 | 0.84 | GPR119 (0.49) | GPR119MEN1KMT2A | |
| SCHEMBL1881361 | 0.84 | GPR119 (0.49) | GPR119ALDH1A1MAPT | |
| SCHEMBL21824778 | 0.82 | MAOA (0.51) | GPR119MAOAMAOBALDH1A1KMT2A | |
| SCHEMBL21825012 | 0.82 | MAOA (0.51) | GPR119MAOAMAOBALDH1A1KMT2A | |
| SCHEMBL5091205 | 0.79 | GPR119 (0.79) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210392895-A1 | NOVEL OXADIAZOLES | PI INDUSTRIES LIMITED (IN) | 2021-12-23 | — | — | US | disclosed |
| WO-2020070610-A1 | NOVEL OXADIAZOLES | PI INDUSTRIES LTD. (IN) | 2020-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210392895-A1 | NOVEL OXADIAZOLES | OXA1L, CYP1B1, CYP1A1 | GPR119 741/4885MAOA 423/4885MAOB 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.